AL-15469A for the Treatment of Bacterial Conjunctivitis

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Fluoroquinolones; Moxifloxacin; Norgestimate, ethinyl estradiol drug combination; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• signs and symptoms of bacterial conjunctivitis

• Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

• under 1 mo. age

• Other protocol-defined exclusion criteria may apply